Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Gregson, J.
1999.
Venlafaxine and paroxetine in treatment-resistant depression.
British Journal of Psychiatry,
Vol. 175,
Issue. 6,
p.
591.
Malhi, G. S.
and
Farmer, A. E.
1999.
Drug therapy in treatment-resistant depression.
British Journal of Psychiatry,
Vol. 175,
Issue. 4,
p.
390.
Mace, Shubhra
and
Taylor, David
2000.
Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression.
Expert Opinion on Pharmacotherapy,
Vol. 1,
Issue. 5,
p.
917.
Hickle, Ian B
2000.
An approach to managing depression in general practice.
Medical Journal of Australia,
Vol. 173,
Issue. 2,
p.
106.
Woods, Scott W.
2000.
Pharmacoeconomic studies of antidepressants: Focus on venlafaxine.
Depression and Anxiety,
Vol. 12,
Issue. S1,
p.
102.
Thase, Michael E.
Friedman, Edward S
and
Howland, Robert H.
2000.
Venlafaxine and treatment-resistant depression.
Depression and Anxiety,
Vol. 12,
Issue. S1,
p.
55.
Daniels, S.
2000.
Drug treatment for resistant depression.
British Journal of Psychiatry,
Vol. 176,
Issue. 4,
p.
398.
Thase, Michael E
and
Sachs, Gary S
2000.
Bipolar depression: pharmacotherapy and related therapeutic strategies.
Biological Psychiatry,
Vol. 48,
Issue. 6,
p.
558.
Béı̈que, Jean-Claude
de Montigny, Claude
Blier, Pierre
and
Debonnel, Guy
2000.
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. In vivo electrophysiological studies in the rat.
Neuropharmacology,
Vol. 39,
Issue. 10,
p.
1800.
Staab, Jeffrey P.
and
Evans, Dwight L.
2000.
Efficacy of venlafaxine in geriatric depression.
Depression and Anxiety,
Vol. 12,
Issue. S1,
p.
63.
Bourin, Michel
Chue, Pierre
and
Guillon, Yannick
2001.
Paroxetine: A Review.
CNS Drug Reviews,
Vol. 7,
Issue. 1,
p.
25.
Harro, Jaanus
and
Oreland, Lars
2001.
Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus.
Brain Research Reviews,
Vol. 38,
Issue. 1-2,
p.
79.
Melichar, Jan K.
Haida, Abel
Rhodes, Chris
Reynolds, Alan H.
Nutt, David J.
and
Malizia, Andrea L.
2001.
Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteers.
Journal of Psychopharmacology,
Vol. 15,
Issue. 1,
p.
9.
Blier, Pierre
Haddjeri, Nasser
Szabo, Steven T
and
Dong, Jianming
2001.
Enhancement of serotoninergic function — a sometimes insufficient cause of antidepressant action.
Human Psychopharmacology: Clinical and Experimental,
Vol. 16,
Issue. 1,
p.
23.
Thase, Michael E.
Entsuah, A. Richard
and
Rudolph, Richard L.
2001.
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.
British Journal of Psychiatry,
Vol. 178,
Issue. 3,
p.
234.
Olver, James S.
Burrows, Graham D.
and
Norman, Trevor R.
2001.
Third-Generation Antidepressants.
CNS Drugs,
Vol. 15,
Issue. 12,
p.
941.
Kennedy, Sidney H
Eisfeld, Beata S
Meyer, Jeffrey H
and
Bagby, R Michael
2001.
Antidepressants in clinical practice: limitations of assessment methods and drug response.
Human Psychopharmacology: Clinical and Experimental,
Vol. 16,
Issue. 1,
p.
105.
Hardy, Julia
Argyropoulos, Spilios
and
Nutt, David J
2002.
Venlafaxine: a new class of antidepressant.
Hospital Medicine,
Vol. 63,
Issue. 9,
p.
549.
Stahl, Stephen M
Entsuah, Richard
and
Rudolph, Richard L
2002.
Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
Biological Psychiatry,
Vol. 52,
Issue. 12,
p.
1166.
Blier, Pierre
and
Ward, Herbert
2002.
Toward Optimal Treatments for Major Depression.
CNS Spectrums,
Vol. 7,
Issue. 2,
p.
148.
eLetters
No eLetters have been published for this article.